A combination process including ionizing radiation for hygienization and shelf life extension of leafy vegetables

474-486Raw leafy greens are commonly associated with global foodborne outbreaks due to pathogenic contaminants. In the current study, greens, such as spinach (Spinacia oleracea L.), coriander (Coriandrum sativum L.) and mint (Mentha spicata L.) showed presence of coliforms (including E. coli)along with other aerobic microbes, yeast and molds. These vegetables mostly consumed in raw or culinary purpose, and hence increase the chances of food borne illnesses. Moreover, the leafy greens are perishable. In this context, we optimized a combination process including radiation treatment to achieve hygienization and shelf life extension of these leafy green vegetables. The combination treatment comprising potable water wash, chlorination (NaOCl-200 ppm) followed by irradiation (2 kGy using electron beam or gamma) was developed, and the processed samples showed keeping quality up to 15 days at 4-6°C, whereas control samples spoiled within two days. The treatment resulted in coliform count below detection level while retaining the nutritional, phenolic content and organoleptic qualities. Thus, the combination treatment could ensure safety, keeping quality enhancement of perishable leafy greens and to control global food outbreaks. Electron beam over gamma processing found to be a commercial viable option due to its high throughput and equal efficacy in microbial decontamination

A combination process including ionizing radiation for hygienization and shelf life extension of leafy vegetables

Raw leafy greens are commonly associated with global foodborne outbreaks due to pathogenic contaminants. In the current study, greens, such as spinach (Spinacia oleracea L.), coriander (Coriandrum sativum L.) and mint (Mentha spicata L.) showed presence of coliforms (including E. coli)along with other aerobic microbes, yeast and molds. These vegetables mostly consumed in raw or culinary purpose, and hence increase the chances of food borne illnesses. Moreover, the leafy greens are perishable. In this context, we optimized a combination process including radiation treatment to achieve hygienization and shelf life extension of these leafy green vegetables. The combination treatment comprising potable water wash, chlorination (NaOCl-200 ppm) followed by irradiation (2 kGy using electron beam or gamma) was developed, and the processed samples showed keeping quality up to 15 days at 4-6°C, whereas control samples spoiled within two days. The treatment resulted in coliform count below detection level while retaining the nutritional, phenolic content and organoleptic qualities. Thus, the combination treatment could ensure safety, keeping quality enhancement of perishable leafy greens and to control global food outbreaks. Electron beam over gamma processing found to be a commercial viable option due to its high throughput and equal efficacy in microbial decontaminatio

Genetic Patterns of Domestication in Pigeonpea (Cajanus cajan (L.) Millsp.) and Wild Cajanus Relatives

Pigeonpea (Cajanus cajan) is an annual or short-lived perennial food legume of acute regional importance, providing significant protein to the human diet in less developed regions of Asia and Africa. Due to its narrow genetic base, pigeonpea improvement is increasingly reliant on introgression of valuable traits from wild forms, a practice that would benefit from knowledge of its domestication history and relationships to wild species. Here we use 752 single nucleotide polymorphisms (SNPs) derived from 670 low copy orthologous genes to clarify the evolutionary history of pigeonpea (79 accessions) and its wild relatives (31 accessions). We identified three well-supported lineages that are geographically clustered and congruent with previous nuclear and plastid sequence-based phylogenies. Among all species analyzed Cajanus cajanifolius is the most probable progenitor of cultivated pigeonpea. Multiple lines of evidence suggest recent gene flow between cultivated and non-cultivated forms, as well as historical gene flow between diverged but sympatric species. Evidence supports that primary domestication occurred in India, with a second and more recent nested population bottleneck focused in tropical regions that is the likely consequence of pigeonpea breeding. We find abundant allelic variation and genetic diversity among the wild relatives, with the exception of wild species from Australia for which we report a third bottleneck unrelated to domestication within India. Domesticated C. cajan possess 75% less allelic diversity than the progenitor clade of wild Indian species, indicating a severe “domestication bottleneck” during pigeonpea domestication

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy

Magnetic liposome-mediated combined chemotherapy and hyperthermia is gaining importance as an effective therapeutic modality for cancer. However, control and maintenance of optimum hyperthermia are major challenges in clinical settings due to the overheating of tissues. To overcome this problem, we developed a novel magnetic liposomes formulation co-entrapping a dextran coated biphasic suspension of La0.75Sr0.25MnO3 (LSMO) and iron oxide (Fe3O4) nanoparticles for self-controlled hyperthermia and chemotherapy. However, the general apprehension about biocompatibility and safety of the newly developed formulation needs to be addressed. In this work, in vitro and in vivo biocompatibility and therapeutic evaluation studies of the novel magnetic liposomes are reported. Biocompatibility study of the magnetic liposomes formulation was carried out to evaluate the signs of preliminary systemic toxicity, if any, following intravenous administration of the magnetic liposomes in Swiss mice. Therapeutic efficacy of the magnetic liposomes formulation was evaluated in the fibrosarcoma tumour bearing mouse model. Fibrosarcoma tumour-bearing mice were subjected to hyperthermia following intratumoral injection of single or double doses of the magnetic liposomes with or without chemotherapeutic drug paclitaxel. Hyperthermia (three spurts, each at 3 days interval) with drug loaded magnetic liposomes following single dose administration reduced the growth of tumours by 2.5 fold (mean tumour volume 2356 +/- 550 mm(3)) whereas the double dose treatment reduced the tumour growth by 3.6 fold (mean tumour volume 1045 +/- 440 mm(3)) compared to their corresponding control (mean tumour volume 3782 +/- 515 mm(3)). At the end of the tumour efficacy studies, the presence of MNPs was studied in the remnant tumour tissues and vital organs of the mice. No significant leaching or drainage of the magnetic liposomes during the study was observed from the tumour site to the other vital organs of the body, suggesting again the potential of the novel magnetic liposomes formulation for possibility of developing as an effective modality for treatment of drug resistant or physiologically vulnerable cancer

Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application

In this study, lauric acid-coated, superparamagnetic, nanoparticle-based magnetic fluids of different ferrites (Fe3O4, MnFe2O4, and CoFe2O4) were prepared and compared in terms of heating ability and biocompatibility to evaluate the feasibility of use in hyperthermia treatment of cancer. All the magnetic fluids prepared had particles of average sizes 9-11 nm. Heating ability of these magnetic fluids was evaluated by calorimetric measurement of specific absorption rate (SAR) at 300 kHz frequency and 15 kA/m field. Fe3O4 and MnFe2O4 showed higher SAR (120 and 97 W/g of ferrite, respectively) than CoFe2O4 (37 W/g of ferrite). In vitro study on BHK 21 cell lines showed dose-dependent cell viability for all the magnetic fluids. Threshold-biocompatible ferrite concentration for all the magnetic fluids was 0.1 mg/mL. Above 0.2 mg/mL, CoFe2O4 was more toxic than the other magnetic fluids. On intravenous injection of different doses (50, 200, and 400 mg/kg body weight) of magnetic fluids in mice, no significant changes in hematological and biochemical parameters were observed for Fe3O4 and MnFe2O4. With CoFe2O4, an increase in SGPT levels at a dose rate of 400 mg/kg body weight was observed, indicating its mild hepatotoxic effect. However, histology of different vital organs showed no pathological changes for all the three magnetic fluids. Further, long term in vivo evaluation of biocompatibility of the lauric acid-coated ferrites is warranted. This study shows that lauric acid-coated, superparamagnetic Fe3O4 and MnFe2O4 may be used for hyperthermia treatment and are to be preferred over CoFe2O4. (c) 2006